Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Senard

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
British Journal of Pharmacology|August 1, 1990
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxanJ Galitzky, J M Senard, M Lafontan, et al.
Therapie|January 1, 1994
[Apropos of secondary effects of hydroxyzine]P Pascali, F Sorbette, J M Senard, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1989
Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivoM Galinier, J M Senard, P Valet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Does fluoxetine aggravate Parkinson's disease? A pilot prospective studyJ L Montastruc, N Fabre, O Blin, et al.
British Journal of Clinical Pharmacology|July 1, 1993
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in manP Barbe, J Galitzky, D Riviere, et al.
Therapie|September 1, 1992
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]M Lapeyre-Mestre, B Chave, O Rascol, et al.
Clinical Neuropharmacology|June 1, 1996
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's diseaseO Rascol, A J Lees, J M Senard, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humansP Barbe, J Galitzky, C Thalamas, et al.
Neurology|September 1, 1988
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trialO Rascol, J L Montastruc, J M Senard, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case reportJ M Senard, A Arias, M Berlan, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
British Journal of Pharmacology|August 1, 1990
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxanJ Galitzky, J M Senard, M Lafontan, et al.
Therapie|January 1, 1994
[Apropos of secondary effects of hydroxyzine]P Pascali, F Sorbette, J M Senard, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1989
Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivoM Galinier, J M Senard, P Valet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Does fluoxetine aggravate Parkinson's disease? A pilot prospective studyJ L Montastruc, N Fabre, O Blin, et al.
British Journal of Clinical Pharmacology|July 1, 1993
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in manP Barbe, J Galitzky, D Riviere, et al.
Therapie|September 1, 1992
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]M Lapeyre-Mestre, B Chave, O Rascol, et al.
Clinical Neuropharmacology|June 1, 1996
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's diseaseO Rascol, A J Lees, J M Senard, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humansP Barbe, J Galitzky, C Thalamas, et al.
Neurology|September 1, 1988
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trialO Rascol, J L Montastruc, J M Senard, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case reportJ M Senard, A Arias, M Berlan, et al.
Pageof 13